About the Program | About the Branches | Current Research | Key Initiatives | What's New

Past Bulletins and News Flashes - 2003

News Flash, September 23, 2003 NIH Notice About Grant Application Submission Delays Due To Hurricane Isabel Below from the NIH Guide for Grants and Contracts Release Date: September 22, 2003 Notice: NOT-OD-03-064 Hurricane Isabel has led to the closure of institutions on the East Coast and the Federal government in the Washington, D.C. area. The NIH realizes that this may cause problems for investigators who are planning on submitting grant applications. Applications that are submitted late because of problems caused by Hurricane Isabel should include a cover letter noting the reasons for the delay. It is not necessary to get permission in advance for hurricane-related delays in grant application submission. It is expected that the delay will generally not exceed the time period that an institution is closed. Update, September 5, 2003 Update from Edward Trapido, Sc.D. Associate Director, Epidemiology and Genetics Research Program (EGRP) This is a brief message to let you know that we'll be at the annual meeting of the American College of Epidemiology (ACE) in Chicago, Sept. 7-9, and to tell you some recent news about our grantees and activities of the Epidemiology and Genetics Research Program (EGRP). (more...) News Flash, July 7, 2003 Croyle Named Head of NCI Division of Cancer Control and Population Sciences The National Cancer Institute (NCI) has announced the appointment of Robert T. Croyle, Ph.D., as director of its Division of Cancer Control and Population Sciences (DCCPS). Croyle has been the acting division director since November 2002, and is the division's former associate director for behavioral research. Croyle brings to the position a wealth of experience in cancer control research, including work ranging from prevention to survivorship. He has been an advocate for and collaborator on many cross-cutting issues such as transdisciplinary science, genetic testing, genetic epidemiology, health promotion, measurement, and dissemination. Croyle is responsible for building DCCPS' highly regarded Behavioral Research Program, where he spent four years contributing to some of NCI's highest priority areas. The division's major initiatives include cancer communications, health disparities, quality of care, genes and the environment, treatment outcomes and quality of life for cancer survivors, and tobacco control - important areas of investment that span the continuum of discovery, development, and delivery. In his leadership role, Croyle is responsible for 170 employees (excluding interns, fellows, and federal contractors), almost 800 extramural grants valued at over $365 million, over $22 million in contracts, and an additional $75 million in operating budgets for programs and branches. "I am thrilled to have the opportunity to continue my work with the division [of Cancer Control and Population Sciences]," said Croyle. "I couldn't ask for more hard-working, intelligent, and creative colleagues than the ones I've had the pleasure of working with over the past five years. DCCPS is on the cutting edge of research in epidemiology and genetics, behavior, health services, surveillance, and survivorship. It's an exciting place to be." Before joining NCI in 1998, Croyle worked at three academic institutions and two cancer centers. He spent nine years as a professor of psychology, member of the Huntsman Cancer Institute, and member of the Genetic Science in Society Program at the University of Utah in Salt Lake City. Prior to that, he was a visiting investigator at the Fred Hutchinson Cancer Research Center in Seattle, visiting assistant professor of psychology at the University of Washington, and assistant professor of psychology at Williams College in Massachusetts. "I am very pleased that Dr. Croyle has accepted the position. He brings leadership experience and expertise in the many facets of cancer control research. He is an energetic leader and a person who will further NCI's high standards for research, collaboration, and outreach," said NCI Director Andrew von Eschenbach, M.D. Croyle received his Ph.D. in social psychology from Princeton University in 1985, and graduated Phi Beta Kappa with a B.A. in psychology from the University of Washington in 1978. His recent research has examined how individuals process, evaluate, and respond to disease risk information, including medical diagnoses, risk factor screening, and tests for BRCA1 and BRCA2 mutations. His research has been published in professional journals in behavioral science, public health, and cancer, and he has edited two volumes, Mental Representation in Health and Illness (1991) and Psychosocial Effects of Screening for Disease Prevention and Detection (1995). He is a member of the Academy of Behavioral Medicine Research and a fellow of the Society of Behavioral Medicine. His service on journal editorial boards includes positions as an associate editor for Cancer Epidemiology, Biomarkers and Prevention, and a consulting editor for Health Psychology and the British Journal of Health Psychology. Bulletin, April 22, 2003 This Epidemiology and Genetics Research Program (EGRP) Bulletin provides information about research funding, research resources, and policies and procedures important for grantees and grant applicants who may be supported through its Program. Our aim is to help you successfully navigate the grant application process and to support your research efforts. EGRP manages a comprehensive program of grant-supported, population-based research to increase our understanding of cancer etiology and prevention. Funding Opportunities NCI Articulates Future Plans Comprehensive Cancer Data on Women of Color Published Research Resources Provided by EGRP Cancer Family Registries for Breast/Ovarian and Colon Cancer Cancer Genetics Network Geographic Information System for Breast Cancer and Other Research Need Help Identifying Sources of Human Specimens and Data? Final Statement on Sharing Research Data Published New Practice on Resubmission of Certain Applications “Other Support” Information Must Be Provided Before an Award Can Be Made Advance Notice Required To Submit Large Budget Applications Increased Support for Competing Continuations Capped Impact of HIPAA Privacy Rule on NIH Grantees Explained Sources of Information on Grant Policies, Funding, Training EGRP Staff News Flash, March 5, 2003 NCI's Latest Planning and Budget Document Now Available The National Cancer Institute’s (NCI) planning and budget proposal for Fiscal Year 2004, The Nation's Investment in Cancer Research, is now available on-line or in print. This document communicates NCI’s vision and plans for the future and is a guide for operational planning and priority setting. In releasing the report, NCI Director Andrew C. von Eschenbach, M.D., said the document is built around the discovery-development-delivery continuum, and a framework that emphasizes capacity building, accelerating discovery and its application, and addressing areas of public health emphasis. The Epidemiology and Genetics Research Program (EGRP) recommends reading the document and encourages you to consider it in planning your research. In grant applications, we suggest referring to relevant sections or passages, when appropriate, and indicating how the proposed research contributes to NCI’s plans. Of particular interest to investigators in cancer epidemiology may be the sections on: Genes and the environment, an area identified as an Extraordinary Opportunity for Investment where focused research can produce dramatic progress toward reducing the burden of cancer. The goal is to discover genetic, environmental, and lifestyle factors and their interactions that define cancer risk and inform strategies for cancer control. Reducing cancer-related health disparities. The goal is to understand the fundamental causes of health disparities in cancer, develop effective interventions to reduce these disparities, and facilitate their implementation. Research on tobacco and tobacco-related cancers. The goal is to understand the causes of tobacco use, addiction, and tobacco-related cancers and apply this knowledge to their prevention and treatment. Special sections of the document also point to crosscutting themes for disease-specific research and research directed toward a better understanding of the interface of aging and cancer. New priority areas focus attention on the tumor microenvironment and on cancer survivorship. New objectives emphasize studies of cancer and the immune system, molecular biosensors, nanotechnology, palliative care, and symptom management. Access the document on-line, or order a print copy from NCI’s On-line Publications Locator Service. News Flash, February 20, 2003 Delays in Grant Application Submissions, Practices Changed for Resubmission of Certain Applications Delays in Grant Application Submissions The recent winter storms have led to closures of institutions and the Federal Government. The NIH realizes that this may cause problems for investigators who are submitting grant applications for special receipt dates (RFAs and PARs) for the week of February 17, 2003. Applications for special receipt dates that are submitted late because of the recent storms should include a cover letter noting the reasons for the delay. It is not necessary to get permission in advance for weather-related delays in grant application submission; please do not call the Division of Receipt and Referral to request such permission. It is important that these applications be received by NIH no later than February 26 so that they can be identified before the arrival of the March 1 unsolicited applications. Because March 1 falls on a Saturday, applications will be on time if they are sent by Monday, March 3, 2003. The critical date is the submission date, not the arrival date. If the recent storms or other extraordinary circumstances lead to a delay in submission for March 3, please include a cover letter explaining the reasons for the delay; again, please do not call to request permission to be late. The above notice, NOT-OD-03-030, appeared in the NIH Guide for Grants and Contracts; release date: February 19, 2003. NIH Changes Practice for Resubmission of Unpaid RFAs and Applications with Changed Grant Activity Mechanism NIH is changing its practice regarding resubmission of unpaid applications received in response to Request for Applications (RFA) and applications with changed grant activity mechanisms. The change affects three categories of applications: Applications that were originally submitted in response to an RFA and then resubmitted as an investigator-initiated application.   Applications that were originally submitted as investigator-initiated applications and subsequently resubmitted in response to an RFA.   Applications that were originally submitted using one grant mechanism and subsequently resubmitted using a different grant mechanism (for example, an application that was originally an R01 and then is resubmitted as an R21). This change was announced in a Notice in the NIH Guide. The Notice explains that since an RFA often has special considerations of eligibility, scientific scope, and review criteria, it is felt that most unfunded applications should be resubmitted as NEW applications. Submission of a new application will allow the applicant to fully benefit from the NIH policy that allows an applicant to submit two revisions within two years. Also, applicants can benefit from considering comments made in summary statements in the preparation of their new application. Full details appear in the Notice, NOT-OD-O3-019; release date: January 16, 2003.

Search | Help | Contact Us | Accessibility